Cynomys
Develops solutions aimed at improving human health, increasing animal welfare and protecting the territory, to ensure productivity efficiency and an increase in quality of life.
Launch date
Employees
Market cap
-
Enterprise valuation
$9—14m (Dealroom.co estimates Mar 2024.)
Genoa Liguria (HQ & founding location)
Financials
Estimates*
EUR | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m |
% growth | - | (14 %) | 384 % | 75 % | - |
EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | - |
% EBITDA margin | (688 %) | (652 %) | (183 %) | (48 %) | - |
Profit | (<1m) | (<1m) | (<1m) | (<1m) | - |
% profit margin | (713 %) | (706 %) | (208 %) | (76 %) | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Seed | |
* | €2.1m | Early VC | |
Total Funding | $2.3m |
Related Content
Recent News about Cynomys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.